
Let's Combinate in 2026
44 episodes, newest first.
- 2 Nov261Getting Pharma/Device Products Into Clinical Trials: INDs, IDEs & FDA Meetings37m
- 26 Oct267What Pharma Wants from CDMOs: Quality, Pricing & TrustKaan Kekec19m
- 19 Oct259The Career Lesson I Learned the Hard Way in Pharma5m
- 12 Oct258Combination Product Quality: Human Factors, CDMO Scorecards, ISO 14971 vs. ICH Q9, with Ben Locwin34m
- 5 Oct25721 CFR Part 4 Explained: CGMP Requirements for Combination Products12m
- 28 Sept256The New FDA Inspection Playbook: Where to Start with QMSR9m
- 21 Sept255Audit Interview Techniques: How Good Auditors Get Better Evidence11m
- 13 Sept254Saying No Is the Easy Part of Quality12m
- 7 Sept253FDA Is Making Big Changes to Its Inspection Approach45m
- 31 Aug252Acceptance Sampling Fundamentals: AQL, Attributes vs Variables, and Risk (OC Curves)13m
- 24 Aug251The Future of Drug Delivery: Orals, Injectables, Sustainability & Device Strategy49m
- 18 AugI'm Changing The Podcast2m
- 12 Aug250PIC/S PI 006-4 (2026): What Changed in Qualification & Validation?11m
- 5 Aug249The Best Audit Advice Nobody Told Me14m
- 29 Jul248What Is a Quality Unit? QA vs. QC Explained8m
- 22 Jul247Why Everyone in Pharma and MedTech Should Work in Quality8m
- 15 Jul246The 3 Ways to Structure a Quality Management System (Centralized vs. Federated vs. Decentralized)8m
- 8 Jul245Reducing a 14-Step Emergency Injection to a Two-Step Auto-Injector45m
- 1 Jul2445 Critical Quality Differences Between Drugs and Devices8m
- 24 Jun243Why Kitting A Finished Medical Device with a Drug Create So Much Work14m
- 17 Jun242Pharma/MedTech Audits: 6 Strategies for Choosing Where to Start12m
- 10 Jun241ICH Q14 Explained: Have We Been Validating Methods Backwards?10m
- 3 Jun240ICH Q13: Continuous Manufacturing, Batches, Residence Time Distribution and Control Strategy11m
- 27 May239ICH Q12: What’s Binding? Established Conditions and Post-Approval Changes10m
- 20 May239ICH Q11 in 6 Minutes6m
- 13 May2386 Audit Strategies Every Auditor Should Know10m
- 6 May237ICH Q10: The Pharmaceutical Quality System8m
- 29 Apr236ICH Q9: Quality Risk Management (QRM) + ISO 14971 Differences12m
- 22 Apr235ICH Q8: How Pharmaceutical Development Actually Works10m
- 15 Apr234ICH Q7: The GMP Framework for API Manufacturing13m
- 8 Apr233Most Teams Misunderstand SpecificationsICH Q66m
- 1 Apr232MedTech Material Selection: Cost, Compliance, Sustainability, and Biocompatibility Risk34m
- 25 Mar231Audit Findings Explained: Nonconformity vs Observation (CQA)11m
- 23 Mar230How Pharma Misses Critical Market Signals with Joe Luminiello30m
- 11 Mar229 -Outsourcing Analytical Testing: What Sponsors Get Wrong in Combination Products31m
- 4 Mar228ICH Q5 EXPLAINED: Why Regulators Treat Biologics Differently6m
- 24 Feb227When Should You Open a CAPA? Triggers, Human Error, and Investigation Basics28m
- 18 Feb226Navigating China NMPA Medical Device RequirementsStandards, GMP Updates, Agents & Classification29m
- 11 Feb226ICH Q4 Explained: How Pharmacopeial Methods Are Accepted Across Regions8m
- 4 Feb225ICH Q3A, Q3B, Q3C, Q3D and Q3E - EXPLAINED in 10 Minutes9m
- 28 Jan224ICH Q2 Explained: What Analytical Validation Really Requires10m
- 21 Jan223What’s Changing in ICH Q1 and What Isn’t: Understanding Stability Expectations9m
- 14 Jan222How ICH Guidelines Are Organized: Understanding the Q, S, E, and M Series12m
- 7 Jan221What Is ICH and Why It Matters14m